Therapies targeting novel inhibitory and stimulatory immune
checkpoints have been shown to possess substantial therapeutic potential, both
as monotherapies and in combination with other interventions, across multiple
disease interventions
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Next
Generation Immune Checkpoint Inhibitors and Stimulators
Market, 2020-2030.”
The report features an extensive study of the current
market landscape, offering an informed opinion on the likely adoption of these
therapies over the next decade. It features an in-depth analysis, highlighting
the capabilities of various stakeholders engaged in this domain. In addition to
other elements, the study includes:
§
§
§
§
§
§
§
§
- Target
Disease Indication
§
§
§
§
§
§
§
§
§
§
- Target
Immune Checkpoint
§
§
§
§
§
- Mechanism
of Action
§
§
- Therapeutic
Modality
§
§
- Type
of Therapy
§
§
- Route
of Administration
§
§
§
- Key
Geographical Region
§
§
§
Key
companies covered in the
§
§
§
§
§
For
more information plea se click on
the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings
1.
2.
3.
About Roots Analysis
Roots Analysis is one of the fastest growing market
research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
